Do you want BuboFlash to help you learning these things? Or do you want to add or correct something? Click here to log in or create user.


  • Presentation
  • Question
  • Answer

Question
Patients with HCV genotype 2 have a very high likelihood of sustained virologic response with [...], and therefore treatment should be initiated with these agents.
Answer
sofosbuvir and ribavirin

Question
Patients with HCV genotype 2 have a very high likelihood of sustained virologic response with [...], and therefore treatment should be initiated with these agents.
Answer
?

Question
Patients with HCV genotype 2 have a very high likelihood of sustained virologic response with [...], and therefore treatment should be initiated with these agents.
Answer
sofosbuvir and ribavirin
If you want to change selection, open original toplevel document below and click on "Move attachment"

Parent (intermediate) annotation

Open it
Patients with HCV genotype 2 have a very high likelihood of sustained virologic response with sofosbuvir and ribavirin, and therefore treatment should be initiated with these agents.

Original toplevel document (pdf)

owner: ELBOMBARDO - (no access) - MKSAP_17.pdf, p2687

Summary

statusnot learnedmeasured difficulty37% [default]last interval [days]               
repetition number in this series0memorised on               scheduled repetition               
scheduled repetition interval               last repetition or drill

Details

No repetitions

Discussion

Do you want to join discussion? Click here to log in or create user.